HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Li Selected Research

paclitaxel poliglumex (XYOTAX)

7/2001Potentiation of radioresponse by polymer-drug conjugates.
11/2000Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate.
7/2000Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy.
4/2000Hepatic chemoembolization: clinical and experimental correlation.
1/2000Conjugation of camptothecins to poly-(L-glutamic acid).
1/2000Comparison of action of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in human breast cancer cells.
1/2000Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Li Research Topics

Disease

123Neoplasms (Cancer)
05/2022 - 01/2000
26Infections
08/2020 - 03/2000
20Carcinoma (Carcinomatosis)
08/2021 - 06/2000
20Breast Neoplasms (Breast Cancer)
02/2021 - 01/2000
19Carcinogenesis
02/2019 - 01/2000
18Neoplasm Metastasis (Metastasis)
12/2021 - 04/2000
15Insulin Resistance
06/2021 - 05/2000
13Inflammation (Inflammations)
12/2021 - 10/2000
12Fibrosis (Cirrhosis)
10/2021 - 10/2001
12Periodontitis
10/2018 - 02/2008
11Obesity
11/2019 - 05/2000
10Stomach Neoplasms (Stomach Cancer)
12/2020 - 11/2000
10Colorectal Neoplasms (Colorectal Cancer)
02/2019 - 02/2003
9Body Weight (Weight, Body)
08/2022 - 06/2000
9Rheumatoid Arthritis
01/2022 - 09/2000
8Hypertension (High Blood Pressure)
11/2021 - 05/2000
8Type 2 Diabetes Mellitus (MODY)
09/2020 - 12/2001
8Ischemia
09/2019 - 02/2000
8Lung Neoplasms (Lung Cancer)
08/2019 - 02/2001
8Lymphatic Metastasis
12/2016 - 02/2000
7Adenocarcinoma
12/2021 - 06/2000
7Stroke (Strokes)
01/2019 - 09/2008
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2017 - 08/2001
6Shock
08/2021 - 06/2000
6Sepsis (Septicemia)
06/2020 - 06/2000
6Human Influenza (Influenza)
01/2019 - 02/2014
6Hypoxia (Hypoxemia)
04/2018 - 05/2001
6Urinary Bladder Neoplasms (Bladder Cancer)
01/2018 - 04/2000
6Hepatocellular Carcinoma (Hepatoma)
01/2018 - 11/2001
6Necrosis
01/2017 - 08/2000
6Squamous Cell Carcinoma of Head and Neck
01/2016 - 12/2001
5Osteoarthritis
12/2021 - 04/2001
5Wounds and Injuries (Trauma)
08/2021 - 10/2013
5Osteoporosis
06/2021 - 07/2000
5Pain (Aches)
12/2020 - 12/2008
5Melanoma (Melanoma, Malignant)
10/2020 - 11/2001
5Fever (Fevers)
08/2020 - 10/2001
5Brain Ischemia (Cerebral Ischemia)
09/2019 - 01/2007
5Disease Progression
01/2019 - 02/2001
5Chronic Periodontitis
10/2018 - 07/2006
5Alveolar Bone Loss
04/2018 - 02/2008
5Schizophrenia (Dementia Praecox)
01/2018 - 04/2001
5Prostatic Neoplasms (Prostate Cancer)
01/2017 - 05/2001
4COVID-19
06/2022 - 01/2020
4Thrombosis (Thrombus)
11/2021 - 05/2001
4Pneumonia (Pneumonitis)
10/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

50Proteins (Proteins, Gene)FDA Link
05/2022 - 03/2000
22Messenger RNA (mRNA)IBA
01/2018 - 02/2000
20Glucose (Dextrose)FDA LinkGeneric
06/2021 - 12/2000
18Pharmaceutical PreparationsIBA
09/2020 - 01/2000
17Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2001
16Insulin (Novolin)FDA Link
03/2022 - 02/2000
15DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2000
15MicroRNAs (MicroRNA)IBA
01/2020 - 07/2012
14Biological ProductsIBA
01/2021 - 01/2000
12CytokinesIBA
01/2020 - 06/2000
11EnzymesIBA
01/2022 - 03/2000
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 02/2000
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2020 - 07/2000
10Transforming Growth Factor beta (TGF-beta)IBA
07/2018 - 11/2000
8CholesterolIBA
02/2019 - 10/2000
8Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
10/2018 - 02/2009
8Paclitaxel (Taxol)FDA LinkGeneric
08/2017 - 01/2000
8Phosphotransferases (Kinase)IBA
01/2017 - 06/2000
7Transforming Growth Factors (Transforming Growth Factor)IBA
10/2021 - 05/2001
7Cadherins (E-Cadherin)IBA
10/2021 - 03/2006
7AntigensIBA
10/2016 - 06/2000
7paclitaxel poliglumex (XYOTAX)IBA
07/2001 - 01/2000
6Immunoglobulin G (IgG)IBA
11/2021 - 10/2000
6Therapeutic UsesIBA
12/2019 - 05/2001
6CollagenIBA
07/2018 - 02/2008
6CalciumIBA
06/2018 - 07/2000
6Metalloproteases (Metalloproteinases)IBA
06/2018 - 02/2009
6LeptinIBA
06/2017 - 06/2000
5Antiviral Agents (Antivirals)IBA
06/2022 - 05/2008
5Transcription Factors (Transcription Factor)IBA
05/2022 - 06/2000
5CateninsIBA
05/2021 - 10/2014
5VaccinesIBA
08/2020 - 01/2006
5LipopolysaccharidesIBA
01/2020 - 09/2000
5Matrix Metalloproteinases (MMPs)IBA
10/2018 - 03/2000
5NF-kappa B (NF-kB)IBA
07/2018 - 02/2000
5Transforming Growth Factor beta1 (TGF beta 1)IBA
07/2018 - 11/2000
5Cetuximab (Erbitux)FDA Link
11/2017 - 10/2001
5Interleukin-6 (Interleukin 6)IBA
10/2017 - 05/2001
5Estrogens (Estrogen)FDA Link
01/2017 - 09/2009
5Caspase 3 (Caspase-3)IBA
12/2016 - 11/2001
5Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
05/2015 - 02/2000
5Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2014 - 08/2000
5Amino AcidsFDA Link
08/2010 - 08/2000
4ImmunosorbentsIBA
01/2022 - 01/2008
4Estrogen ReceptorsIBA
02/2021 - 02/2012
4Interleukin-4 (Interleukin 4)IBA
01/2021 - 04/2000

Therapy/Procedure

48Therapeutics
03/2022 - 07/2000
20Drug Therapy (Chemotherapy)
08/2020 - 11/2000
11Radiotherapy
08/2021 - 02/2000
6Ligation
04/2018 - 02/2008
5Aftercare (After-Treatment)
12/2020 - 11/2001
4Chemoradiotherapy
08/2021 - 12/2019
4Lasers (Laser)
08/2021 - 11/2001
4Thyroidectomy
08/2021 - 02/2019